Morgan Stanley Maintains Overweight on Zoetis, Lowers Price Target to $99

Benzinga Newsdesk www.benzinga.com Negative 75.0%

Neg 75% Neu 0% Pos 0%

Morgan Stanley analyst Erin Wright maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $115 to $99.